ANAPTYSBIO, INC
ANAB · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Renton Hollings: Form 4
Insider disclosure · Filed · Report period 01 Oct 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
-
Form 10-KT
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ANAB · 032724106 - Common Stock, par value $0.001 per share
Company details and SEC sources
CIK 0001370053 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ANAB on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 10770 Wateridge Circle, Suite 210, San Diego, CA, 92121
- Incorporated in
- DE
- Fiscal year end
- 30 June
- Former names on EDGAR
- ANAPTYS BIOSCIENCES INC (to 20 Nov 2007)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields